During the past decade, Wojewodzki Szpital Zespolony; Oddzial Reumatologii conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Zespolony; Oddzial Reumatologii". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wojewodzki Szpital Zespolony; Oddzial Reumatologii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Zespolony; Oddzial Reumatologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".